A New Paradigm for Achieving a Rapid Antidepressant Response

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• The significant delay in antidepressant efficacy (4-6 weeks) poses risks like treatment cessation and self-harm.
• Current polypharmacy strategies are often unregulated and linked to adverse effects.
• A need exists for structured approaches to expedite antidepressant response.

Purpose of the Study:

• To introduce the Windows of Antidepressant Response Paradigm (WARP) as a novel framework.
• To conceptualize antidepressant response within distinct time windows.
• To guide clinical practice and research for faster treatment of depressive disorders.

Main Methods:

• The WARP paradigm defines three response windows: immediate (1-2 days), fast (up to 1 week), and slow (1 week onwards).
• Analysis of newer agents (e.g., esketamine, brexpiprazole) and augmentation strategies within the WARP framework.
• Conceptualization of treatment response based on expected timelines.

Main Results:

• WARP categorizes rapid-acting antidepressants in the immediate window and atypical antipsychotic augmentation in the fast window.
• Conventional monotherapy aligns with the slow-response window.
• The paradigm provides a structured understanding of antidepressant action timelines.

Conclusions:

• WARP offers a novel conceptual framework to understand and potentially accelerate antidepressant response.
• This paradigm can guide the development of new antidepressant agents and optimize polypharmacy strategies.
• WARP facilitates a more strategic approach to managing depressive disorders, aiming for quicker symptom relief.